申请人:Plancher Jean-Marc
公开号:US20060100206A1
公开(公告)日:2006-05-11
The present invention relates to compounds of formula
wherein R
1
and R
2
are each independently hydrogen or halogen. The compounds are useful for the treatment and/or prophylaxis of diseases which are associated with the modulation of CB
1
receptors.
本发明涉及以下式的化合物
其中R
1
和R
2
各自独立地是氢或卤素。这些化合物可用于治疗和/或预防与CB
1
受体调节相关的疾病。